Taiwan FDA registration 432617ed5dd9a9c6ef20c3983f7d0ecb
Roche Cobas Blood Gas Electrolyte Analysis System
TW: 羅氏可霸斯血液氣體電解質分析系統
Taiwan·Risk Class 2·Roche Diagnostics International Ltd;; ROCHE DIAGNOSTICS GMBH·Registered Aug 20, 2013 – Aug 20, 2028ActiveRegistration details
- Analysis ID
- 432617ed5dd9a9c6ef20c3983f7d0ecb
- Customs Code
- DHA05602526806
Company information
- Manufacturer Country
- Germany;;Switzerland
- Authorized Representative
- ROCHE DIAGNOSTICS LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1120 血內氣體(PCO2,PO2)及血液pH值試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Aug 20, 2013
- Expiry Date
- Aug 20, 2028
About this record
Access comprehensive regulatory information for Roche Cobas Blood Gas Electrolyte Analysis System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 432617ed5dd9a9c6ef20c3983f7d0ecb and manufactured by Roche Diagnostics International Ltd;; ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices